Five-day course of granulocyte colony-stimulating factor in patients with prolonged neutropenia after adjuvant chemotherapy for breast cancer is a safe and cost-effective schedule to maintain dose-intensity.
Year: 1996
Type: article
Study design: Clinical Trial
Source: Journal of Clinical Oncology
Institution: Vall d'Hebron Hospital Universitari
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W1954545824
